YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(7)
- Austria(1)
- Belgium(3)
- Canada(48)
- China(15)
- Colombia(1)
- Denmark(1)
- Finland(1)
- France(9)
- Germany(36)
- Greece(3)
- Hong Kong(1)
- Hungary(2)
- India(72)
- Ireland(1)
- Israel(2)
- Italia (6)
- Japan(1)
- Latvia(1)
- Luxembourg(1)
- Malta(1)
- Mauritius(1)
- Mexico(1)
- Peru(1)
- Poland(1)
- Portugal(3)
- Singapore(1)
- Slovenia(1)
- South Korea(4)
- Spain(9)
- Sweden(2)
- Switzerland(20)
- Taiwan(2)
- The Czech Republic(1)
- The Netherlands(4)
- Turkey(2)
- Ukraine(1)
- United Kingdom(47)
- United States(613)
- Vietnam(1)
Contract Service Directory
Novasep
Company Headquarters
23 Creek Circle
Boothwyn, PA 19061
United States
Contract Service Directory
- cGMP Synthesis
- Chromatography
- Contract Manufacturing
- Custom Manufacturing
- Custom Synthesis
- Manufacturing, Antibody-Drug Conjugates
- Manufacturing, API
- Manufacturing, API, High Potency
- Manufacturing, Biologics
- Manufacturing, Custom
- Manufacturing, Cytotoxic & High Potency Compounds
- Manufacturing, Vaccines
- Supplier, Equipment
- Supplier, Fine Chemicals
Contract Services Directory
Related Content
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News
Novasep, Exelixis Ink ADC Manufacturing Agreement
Covers the cGMP clinical manufacturing of a next-generation ADC drug candidate.07.06.21
-
APIs | Breaking News | Facilities | Industry News
Novasep Upgrades API Manufacturing Facility
A $7.3 million investment will be made over 3 years to modernize the Mourenx site.06.25.21
-
Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Novasep Expands HPAPI Manufacturing Capacity
Responds to increasing customer demand for manufacturing services for antibody drug conjugates.Tim Wright, Editor, Contract Pharma 05.13.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
Pays more than $800 million to expand global capacity and address growing demand for cell and gene therapy.Contract Pharma Staff 01.15.21
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Sensorion and Novasep Sign Agreement
Covers the development and manufacturing of AAV vectors, a key step for Sensorion’s gene therapy programs.Contract Pharma Staff 11.03.20
-
Breaking News | Facilities | Industry News | Inspections
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
Combines Stelis' bioprocess development capabilities with Merck's bioprocessing equipment05.25.17
-
Regulatory Affairs
The FDA and Metrics
The Agency and industry continue to work together to achieve FDA’s objectivesDavid Lonza, Lachman Consultant Services, Inc. 05.09.17
-
Analytical Services | Drug Development | Fill/Finish | Industry News | Lyophilization
Alcami Invests $5M to Expand SC Ops
Will continue to expand its filling and freeze-drying capabilities05.04.17
-
Porton USA Acquires J-STAR Research for $26M
Expands its research and development capabilities05.01.17
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | R&D
Cobra Biologics Invests $19m in Gene Therapy Mfg. Expansion
Capacity increase in response to customer demand for DNA and viral vector production04.18.17
-
Trump Picks New FDA Commish
Combatting high drug prices and overregulation likely to be high on agendaTim Wright, Editor 04.03.17
-
Breaking News | Industry News | Lyophilization
-
Capsules | Solid Dosage/Semi-solids
Generic Drug Trends
Industry faces tighter capacity, consolidation, and drug pricing uncertaintyEdward S. Price, President, PCI 03.07.17
-
Regulatory Affairs
Whither Washington?
With a new administration, the future of the FDA may be the biggest wildcard in the outlook for CDMOs and their customersGil Roth, President, Pharma & Biopharma Outsourcing Association 03.07.17
-
Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Inspections | Lyophilization
LSNE Completes Two FDA Inspections
FDA PAI and general GMP inspection of two aseptic manufacturing plants and QC laboratory completed successfully03.06.17
-
QA/QC | Regulatory Affairs
FDA’s Quality Agreements Guidance
Evaluation of FDA’s recently issued Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for IndustryPaul Mason, Ph.D., Director of Lachman Consultant Services, Inc. 01.26.17
-
Aseptic Processing | Bio News | Bioanalytical Services | Breaking News | Clinical Trial Materials | Industry News
Amatsigroup Acquires Disposable-Lab
Enhances capabilities in development services for injectable drug products01.20.17
-
Trends Affecting the Generic Drugs Sector in 2017
Tighter capacity, consolidation, and drug pricing uncertainty among issues industry facesEd Price, President, PCI Synthesis 01.06.17
-
APIs | cGMP Manufacture | Drug Development | Facilities
Recipharm Gains Approval for Acquisition of Kemwell Indian Ops
Includes pharma manufacturing and development operations in Bengaluru12.30.16
-
APIs | Cytotoxics and High Potency Manufacturing | Industry News | Inspections
Novasep Custom Mfg. Sites Complete FDA Inspections
Three sites in France and Germany pass U.S. FDA inspection12.20.16
